CGON · CG Oncology, Inc.

NasdaqHealthcareBiotechnology

Cg Oncology Inc Is A Late-Stage Clinical Biopharmaceutical Company Focused On Developing And Commercializing Its Product Candidate, Cretostimogene Grenadenorepvec, For Patients With Bladder Cancer. The Company'S Candidate, Cretostimogene Grenadenorepvec, Is A Targeted Oncolytic Intravesically Delivered Immunotherapy Agent That Is In Two Phase Three Trials (One High-Risk Bcg Unresponsive Nmibc Trial And One Intermediate-Risk Nmibc Trial) And A Phase Two Clinical Study With A Checkpoint Inhibitor For High-Risk Bcg Unresponsive Nmibc Disease.

HealthcareNasdaqUS

FLOAT

68.6M

FREE FLOAT %

77%

SHARES O/S

88.6M

MARKET CAP

$5.47B

EXCHANGE

Nasdaq

COUNTRY

CGON Catalyst History

No catalysts recorded for CGON yet

Day Trader Sniper hasn't classified a publishable catalyst for CGON yet. New events appear here as they're scored.

Be early on the next CGON spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

CGON · CG Oncology, Inc.

CGON Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.